Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

NCT01203878 is registered in ClinicalTrials.gov with Tennessee Clinical Research Center as lead sponsor.

NCT NCT01203878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Lead sponsor
Tennessee Clinical Research Center
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2010
Completion date
November 30, 2011
Enrollment
21 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis